Loading...
A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer
Since the prognosis of advanced biliary tract cancer (aBTC) still remains very poor, new therapeutic approaches, including immunotherapies, need to be developed. In the current study, we conducted an open‐label randomized phase II study to test whether low dose cyclophosphamide (CPA) could improve a...
Na minha lista:
| Udgivet i: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448649/ https://ncbi.nlm.nih.gov/pubmed/28188670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13193 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|